{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T13:30:39Z","timestamp":1771853439581,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006280","name":"Ministerio de Ciencia y Tecnolog\u00c3\u00ada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST105-0210-01-12-01"],"award-info":[{"award-number":["MOST105-0210-01-12-01"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST106-0210-01-15-04"],"award-info":[{"award-number":["MOST106-0210-01-15-04"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST108-2320-B-038 -036"],"award-info":[{"award-number":["MOST108-2320-B-038 -036"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST108-2320-B-038-058-MY3"],"award-info":[{"award-number":["MOST108-2320-B-038-058-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejmech.2020.112193","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T00:42:49Z","timestamp":1582936969000},"page":"112193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"192","author":[{"given":"Hui-Ju","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hsiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Ji","family":"Shiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Chun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony Eight","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Jou","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiow-Lin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112193_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer\u2019s disease","volume":"33","author":"Leon","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2020.112193_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2020.112193_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","article-title":"Shifting from the single to the multitarget paradigm in drug discovery","volume":"18","author":"Medina-Franco","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2020.112193_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A\u00a0perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2020.112193_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/ecp.11.13","article-title":"The use of multi-target drugs in the treatment of neurodegenerative diseases","volume":"4","author":"Van der Schyf","year":"2011","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112193_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112193_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1097-2765(03)00038-8","article-title":"The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase","volume":"11","author":"North","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2020.112193_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-171032","article-title":"Frontal cortex epigenetic dysregulation during the progression of Alzheimer\u2019s disease","volume":"62","author":"Mahady","year":"2018","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2020.112193_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Graff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112193_bib11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.celrep.2017.07.044","article-title":"The transcription factor Sp3 cooperates with HDAC2 to regulate synaptic function and plasticity in neurons","volume":"20","author":"Yamakawa","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2020.112193_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm.2709","article-title":"Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia","volume":"18","author":"Li","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2020.112193_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/emmm.201201923","article-title":"Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer\u2019s disease","volume":"5","author":"Govindarajan","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2020.112193_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/156802611794072605","article-title":"Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies","volume":"11","author":"Ballatore","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib15","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.celrep.2017.07.082","article-title":"The deacetylase HDAC6 mediates endogenous neuritic tau pathology","volume":"20","author":"Tseng","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2020.112193_bib16","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1021\/jm400564j","article-title":"Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer\u2019s disease","volume":"56","author":"Yu","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2020.112193_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","article-title":"The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease","volume":"6","author":"Yang","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2020.112193_bib19","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cmdc.201000322","article-title":"Novel huprine derivatives with inhibitory activity toward beta-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates","volume":"5","author":"Viayna","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112193_bib20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejmech.2015.10.001","article-title":"Donepezil-like multifunctional agents: design, synthesis, molecular modeling and biological evaluation","volume":"121","author":"Wu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12031-008-9139-6","article-title":"The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats","volume":"37","author":"Bar-Am","year":"2009","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112193_bib22","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1021\/jm801292b","article-title":"Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"52","author":"Marco-Contelles","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib23","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.bmc.2017.09.028","article-title":"9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer\u2019s disease treatment","volume":"25","author":"Makhaeva","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijbiomac.2014.06.064","article-title":"Novel tacrine\/acridine anticholinesterase inhibitors with piperazine and thiourea linkers","volume":"70","author":"Hamulakova","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2020.112193_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejmech.2012.12.020","article-title":"Synthesis and biological evaluation of radioiodinated quinacrine-based derivatives for SPECT imaging of Abeta plaques","volume":"60","author":"Fuchigami","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbagen.2011.01.007","article-title":"Structure-activity relationship of acridine derivatives to amyloid aggregation of lysozyme","volume":"1810","author":"Antosova","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2020.112193_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/acsmedchemlett.7b00463","article-title":"Dual GSK-3beta\/AChE inhibitors as a new strategy for multitargeting anti-Alzheimer\u2019s disease drug discovery","volume":"9","author":"Jiang","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112193_bib28","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.2174\/1568026618666180112155424","article-title":"Multicomponent reactions for multitargeted compounds for Alzheimer\u2019s disease","volume":"17","author":"Ismaili","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib29","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.bmcl.2013.02.017","article-title":"Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer\u2019s disease","volume":"23","author":"Romero","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112193_bib30","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood-2006-03-014126","article-title":"Histone deacetylase inhibitors prevent exocytosis of interleukin-1beta-containing secretory lysosomes: role of microtubules","volume":"108","author":"Carta","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2020.112193_bib31","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1158\/1535-7163.MCT-05-0442","article-title":"CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in\u00a0vitro and in\u00a0vivo","volume":"5","author":"Buggy","year":"2006","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112193_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/jm200773h","article-title":"Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells","volume":"55","author":"Kalin","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib33","doi-asserted-by":"crossref","first-page":"9562","DOI":"10.1021\/jm300837y","article-title":"Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries","volume":"55","author":"Suzuki","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in\u00a0vitro drug metabolism data in predicting in\u00a0vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112193_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.vascn.2014.08.002","article-title":"Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations","volume":"70","author":"Jin","year":"2014","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejmech.2020.112193_bib36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"Doan","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112193_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2004.10.007","article-title":"Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier","volume":"288","author":"Wang","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2020.112193_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ejmech.2017.11.092","article-title":"Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities","volume":"143","author":"Chao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib39","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/cmdc.201200300","article-title":"Synthesis and biological evaluation of ortho-aryl N-hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors","volume":"7","author":"Huang","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112193_bib40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fphar.2018.00708","article-title":"Design of diarylheptanoid derivatives as dual inhibitors against class IIa histone deacetylase and beta-amyloid aggregation","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112193_bib41","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1021\/acs.jmedchem.7b00702","article-title":"Donepezil-based central acetylcholinesterase inhibitors by means of a \"bio-oxidizable\" prodrug strategy: design, synthesis, and in\u00a0vitro biological evaluation","volume":"60","author":"Peauger","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112193_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420301604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420301604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:08:18Z","timestamp":1759327698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420301604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":42,"alternative-id":["S0223523420301604"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112193","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112193"}}